• All sections
  • C - Chemistrymetallurgy
  • C07D - Heterocyclic compounds
  • C07D 233/61 - Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms with hydrocarbon radicals, substituted by nitrogen atoms not forming part of a nitro radical, attached to ring nitrogen atoms

Patent holdings for IPC class C07D 233/61

Total number of patents in this class: 358

10-year publication summary

32
22
17
24
24
17
17
26
8
13
2016 2017 2018 2019 2020 2021 2022 2023 2024 2025

Principal owners for this class

Owner
All patents
This class
University of Pittsburgh - Of the Commonwealth System of Higher Education
3131
7
BIAL - Portela & CA, S.A.
224
6
PTC Therapeutics, Inc.
484
6
Bristol-myers Squibb Company
4875
5
Merck Patent GmbH
5850
5
Centre National de La Recherche Scientifique
10350
5
Agency for Science, Technology and Research
3596
5
Institut Curie
576
5
Seren Technologies Limited
9
5
AstraZeneca AB
2933
4
Bayer Pharma AG
1061
4
President and Fellows of Harvard College
5952
4
Takeda Pharmaceutical Company Limited
2708
4
Dana-Farber Cancer Institute, Inc.
2556
4
EA Pharma Co., Ltd.
86
4
Toyama Chemical Co., Ltd.
103
4
Universite de Montpellier
977
4
Nissan Chemical Corporation
1982
4
Compagnie Generale des Etablissements Michelin
4711
4
Hoffmann-La Roche Inc.
3387
3
Other owners 266